There are 449 resources available
218P - DSG2+ cancer stem cells co-located with POSTN+ myofibroblasts in the tumor boundary that determines the efficacy of immunotherapy in non-small cell lung cancer
Presenter: Guangyu Fan
Session: Poster Display session
219P - Leveraging gut metagenomic k-mer signature for the development of a practical and robust model to predict immunotherapy response in NSCLC
Presenter: Jun Zhang
Session: Poster Display session
220P - Advancing lung adenocarcinoma treatment: Establishing KRAS-driven organoids for drug screening
Presenter: Isa Tas
Session: Poster Display session
221P - Single-cell transcriptomics reveals CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non-small cell lung cancer
Presenter: Yaokai Wen
Session: Poster Display session
222P - Mutational variant allele frequency profile as a biomarker of response to immune checkpoint inhibitors in non-small cell lung cancer
Presenter: Ruyun Gao
Session: Poster Display session
224P - Cerebrospinal fluid-based mutation abundance index (MAI) correlated to clinical outcome in leptomeningeal metastasis of non-small cell lung cancer with EGFR mutations
Presenter: Wenjie Zhu
Session: Poster Display session
225P - The potential synergistic mechanism of the combination of osimertinib and furmonertinib (3+3 mode): Evidence from an in vitro experimental study and structural modeling
Presenter: Wenhua Liang
Session: Poster Display session
226P - The PerMediNA initiative: A pilot precision oncology project on lung cancer in North Africa
Presenter: Yosr HAMDI
Session: Poster Display session
227P - Sexual dimorphism in immune profile of early and advanced NSCLC
Presenter: Giulia Mazzaschi
Session: Poster Display session
228P - SMARCA4 inactivation drives aggressiveness in STK11/KEAP1 co-mutant lung adenocarcinomas through the induction of TGFβ signaling
Presenter: alvaro Quintanal-Villalonga
Session: Poster Display session